© B2Bioworld 2018 Eric Schmidt, Alphabet Inc (1st left-hand), Wolfgang Herrmann Technical University Munich, 1st right-hand)Google to invest in science "made in Germany"

February 2018. Google and the Technical University of Munich (TUM) have announced a long-term partnership. The cooperation in Munich will be based on research and innovation in the fields of artificial intelligence, machine learning and robotics. As a “TUM Partner of Excellence”, Google will also donate 1 million euros to the TUM University Foundation, primarily to support talented young researchers. Google is the first non-European company to become an official “Partner of Excellence” for TUM.

TUM and Google signed a master agreement for joint research projects. A key aspect of these activities will be artificial intelligence, including the promotion of innovation. UnternehmerTUM, Center for Innovation and Business Creation at TUM and Germany's leading start-up incubator, recently launched the "AppliedAI Initiative" to support founders and companies in developing and especially applying artificial intelligence. Google will invest an additional amount of around 250,000 euros in this initiative over the next three years through its Munich office in the form of direct funding, material resources and personnel.

Google is becoming a strategic technology partner for the appliedAI (aai3) initiative which is managed by UnternehmerTUM (see photo left to right: Eric Schmidt; Andreas Liebl UnternehmerTUM; Alexander Waldmann, aai3 manager; Wieland Holfelder, Google Site Lead Munich, Wolfgang Herrmann, Rector TUM). This partnership grants appliedAI access to some of the latest Google technologies, which will help drive forward the application of AI.

Sources: Google Germany / Technische Universität München

Back to section

Related Editorial Articles

B2Bioworld offers you background information

Google buys into German competitors’ ecosystem

Expansion of the global commercial vehicle market

Grande gueule” and the fallout of Brexit, CETA, or Trumpeta
Jan Peumans, President of the Belgium’s Flemish Parliament about regional politics in uncertain times for international trade

Physics <> Information <> Biology
A view from quantum optics. Alain Aspect, Professor of Physics at Institut d’Optique and Balzan Prize winner

Roche prepares itself for user innovation
I can imagine a shift and additions in skill sets, predicts Ursula Redeker, CEO of Roche Germany

Synthetic Genomics: Autochthon Biotechnology
Business Strategies for Food, Feed, and Biofuels from Algae. James H Flatt, Chief Technology Officer Synthetic Genomics

European and U.S. Codes of Conduct for Development of Robotics and Artificial Intelligence

Seiko Epson and its Business Perspectives
Venturing into robotics, drones, microfluidics, and other AI – device developments. Includes an interview with Minoru Usui, CEO SeikoEpson

Yamaha’s Flex-Fuel Criss-Crosser
Brazilian DNA to Re-program Honda Moto

De-mystifying Corruption: Identifying, Sanctioning, Monitoring, Preventing

Steering Health Data For or By?
The User as Stakeholder, Expert, Citizen, Consumer, and Patient. Thomas Szucs, Chairman of Swiss Helsana Group

Systems Biology Applied
Rudi Balling, Director of the Luxembourg Centre for Systems Biomedicine, on the need of systems theory thinking in using technologies and pitfalls of some concepts

Disclaimer: You agree that B2Bioworld is not responsible and will not be held liable for any third party content on its sites or any third-party content, products or services available on other web sites accessed through links from B2Bioworld sites. Links to third-party sites are for your convenience only. Their inclusion on B2Bioworld's sites does not imply any endorsement, guarantee, warranty or representation by B2Bioworld.